Halozyme Therapeutics, Inc. (HALO) - Earnings & Price History

HALO: Halozyme Therapeutics, Inc. - 16.94, $2.39B, -0.79 (-4.46%)

Sector: Healthcare - Industry: Biotechnology

Halozyme Therapeutics, Inc., a biotechnology company, researches, develops, and commercializes human enzymes. Its human enzymes are used to facilitate the delivery of injected drugs and fluids, enhancing the efficacy and the convenience of other drugs or can be used to alter tissue structures for clinical benefit. The companys products are based on the Enhanze technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs; in subcutaneous urography; and to enhance resorption of radiopaque agents. The company is also developin

Past HALO reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-28AMC-0.2812.912.8213.2812.0913.283.59%-2.86%0.62%2.24M
2016-11-07AMC-0.279.668.879.158.6310.013.16%▲5.57%8.91%2.73M
2016-08-09AMC-0.2710.0510.410.710.0310.752.88%-6.07%-3.37%1.54M
2016-05-09AMC-0.29.859.729.979.3710.542.57%-1.20%1.34%2.58M
2016-02-29AMC-0.088.748.138.728.499.647.26%0.23%7.50%5.31M
2015-11-09AMC-0.1616.2117.8816.7815.3917-6.15%▲-3.40%-9.34%3.00M
2015-08-10AMC-0.0920.8321.1122.0918.84254.64%-5.70%-1.33%8.61M
2015-03-02AMC-0.0715.2315.2215.5214.6415.561.97%-1.87%0.07%1.67M
2014-11-10AMCHalozyme Thera-0.168.829.328.758.39.08-6.12%▲0.80%-5.36%3.04M
2014-08-11AMCHalozyme Thera-0.18-0.139.910.0610.19.8410.320.40%-1.98%-1.59%1.85M
2014-05-12AMCHalozyme Thera-0.16-0.228.047.528.847.989.3817.55%-9.05%6.91%11.80M
2014-02-27AMCHalozyme Thera-0.17-0.1914.0916.0215.413.515.57-3.87%-8.51%-12.05%6.08M
2013-11-08BMOHalozyme Thera-0.16-0.1712.910.8711.5211.313.525.98%▲11.98%18.68%5.06M
2013-08-07AMCHalozyme Thera-0.14-0.26.757.017.016.517.11-3.71%-3.71%2.54M
2013-05-08AMC6.016.0165.956.21-0.17%0.17%1.26M
2013-02-25BMO5.725.915.915.686.07-3.21%-3.21%1.01M
2012-11-08AMC4.825.134.994.85.29-2.73%▲-3.41%-6.04%1.18M
2012-08-06AMCQ2 2012 Halozyme The6.064.825.024.856.134.15%20.72%25.73%4.42M
2012-05-07AMCQ1 2012 Halozyme The7.667.867.837.297.87-0.38%-2.17%-2.54%1.55M
2012-03-09BMOQ4 2011 Halozyme The11.3911.5111.1310.8211.4-3.30%2.34%-1.04%1.61M
2011-11-07AMCQ3 2011 Halozyme The8.88.428.548.428.931.43%▲3.04%4.51%848.10K
2011-08-05BMOQ2 2011 Halozyme The6.155.816.065.616.94.30%1.49%5.85%679.20K
2011-05-06BMOQ1 2011 Halozyme The6.346.216.326.256.561.77%0.32%2.09%391.40K
2011-03-11BMOQ4 2010 Halozyme Ear6.646.486.796.46.94.78%-2.21%2.47%383.80K
2010-11-05BMOQ3 2010 Halozyme Ear7.497.667.547.437.66-1.57%▲-0.66%-2.22%324.00K
2010-08-06BMOQ2 2010 Halozyme Ear7.317.367.226.837.41-1.90%1.25%-0.68%185.40K
2010-05-07BMOQ1 2010 Halozyme Ear7.097.678.086.548.085.35%-12.25%-7.56%1.29M
2010-03-12BMOQ4 2009 Halozyme Ear-0.17-0.147.317.197.647.087.646.26%-4.32%1.67%861.90K
2009-11-06BMOQ3 2009 Halozyme Ear-0.18-0.166.116.236.186.036.37-0.80%▲-1.13%-1.93%189.80K
2009-08-07BMOQ2 2009 Halozyme Ear-0.17-0.217.417.487.647.347.872.14%-3.01%-0.94%484.30K
2009-05-08BMOQ1 2009 Halozyme Ear-0.16-0.186.435.815.795.66.43-0.34%11.05%10.67%354.90K
2009-03-13BMOQ4 2008 Halozyme Ear-0.13-0.214.934.974.994.815.140.40%-1.20%-0.80%169.80K
2008-11-06Q3 2008 Halozyme Ear-0.144.354.414.584.154.593.85%▲-5.02%-1.36%192.50K
2008-08-08Q2 2008 Halozyme Ear-0.13-0.147.627.536.86.767.62-9.69%12.06%1.20%912.30K
2008-05-08AMCQ1 2008 Halozyme Ear-0.12-0.135.584.944.964.755.770.40%12.50%12.96%391.20K
2008-03-13AMCQ4 2007 Halozyme Ear-0.09-0.114.955.44.854.755.48-10.19%2.06%-8.33%541.00K
2007-11-08AMCQ3 2007 Halozyme Ear-0.06-0.097.788.958.677.728.85-3.13%▲-10.27%-13.07%854.80K
2007-08-09AMCQ2 2007 Halozyme Ear-0.05-0.078.338.958.518.049-4.92%-2.12%-6.93%557.30K
2007-05-10AMCQ1 2007 Halozyme Ear-0.0510.5610.4410.4610.2510.640.19%0.96%1.15%134.10K
2007-03-08BMOQ4 2006 Halozyme Ear-0.06-0.078.68.398.458.358.60.72%1.78%2.50%260.70K
2006-11-09AMCQ3 2006 Halozyme Ear-0.062.62.672.652.62.68-0.75%▲-1.89%-2.62%53.40K
2006-08-10Q2 2006 Halozyme Ear-0.052.32.282.282.282.380.88%0.88%56.40K
2006-05-10BMOQ1 2006 Halozyme Ear-0.062.82.822.812.82.84-0.35%-0.36%-0.71%75.90K
2006-03-23BMOQ4 2005 Halozyme Ear-0.06-0.073.493.483.53.353.710.57%-0.29%0.29%438.20K
2005-11-11BMOQ3 2005 Halozyme Ear-0.06-0.071.811.81.851.791.852.78%▲-2.16%0.56%56.40K
2005-08-08BMOQ2 2005 Halozyme Ear-0.061.71.671.671.671.71.80%1.80%7.20K
2005-05-13BMOQ1 2005 Halozyme Ear-0.061.841.871.881.841.880.53%-2.13%-1.60%15.30K
2005-03-09BMOQ4 2004 Halozyme Ear1.841.921.911.82.02-0.52%-3.66%-4.17%426.20K
2004-11-12BMOQ3 2004 Halozyme Ear2.452.192.12.12.79-4.11%▲16.67%11.87%82.20K
2004-08-16BMOQ2 2004 Halozyme Ear1.92.12.151.852.22.38%-11.63%-9.52%278.50K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades